Filters
Returns: Low to High
Total Result:
16
Themes Found.
⚡ Power & Energy Portfoli...
DEVARSH JIGISH SHAH
Publish on 20 Apr, 2026
India’s power sector is entering a massive growth phase, driven by strong government push and rising energy demand. With over ₹24 lakh crore planned investment under the National Infrastructure Pipeline and an estimated $500 billion capex expected over the next decade, the sector is set to see long-term expansion across generation, transmission, and distribution. India is already the world’s 3rd largest power consumer, and with growth in manufacturing, electric vehicles, data centers, and renewable energy, electricity demand is expected to grow faster than GDP for the next 10+ years. This creates huge opportunities for companies involved in: Power equipment (transformers, cables, switchgear) EPC and infrastructure Grid modernization and transmission Renewable energy and energy-tech solutions We select companies that are well-positioned to benefit from this multi-year growth cycle, with strong order books, improving financials, and scalable business models. By investing in this portfolio, you get exposure to India’s long-term power and infrastructure growth story.
Min. Amount
₹ 33224.24
1D Return
0
Volatility
-
Digital Banking & IT Tran...
Gautam Patel
Publish on 11 Apr, 2026
The Digital Banking & IT Transformation theme focuses on the convergence of financial services and technology, combining leading IT service providers with a key banking player undergoing digital evolution. With companies like YESBANK, TCS, and INFY, this theme aims to capture growth driven by digital banking adoption, fintech innovation, and enterprise technology transformation. The portfolio is positioned to benefit from increasing demand for scalable IT solutions, modernization of financial infrastructure, and the shift toward data-driven and customer-centric banking models. It is well-suited for investors looking to gain exposure to both financial sector recovery and long-term technology growth.
Min. Amount
₹ 13.26
1D Return
0
Volatility
-
AI & Technology Growth
Gautam Patel
Publish on 11 Apr, 2026
Focused on companies leading innovation in artificial intelligence, cloud computing, and next-gen software solutions.
Min. Amount
₹ 35.49
1D Return
0
Volatility
-
theme 2
Abhi
Publish on 13 May, 2026
test theme 2
Min. Amount
₹ 4440.96
1D Return
0
Volatility
-
IT boomers
Sejpalsinh Jadeja
Publish on 16 Apr, 2026
IT companies who are going to die soon because of AI
Min. Amount
₹ 6215.80
1D Return
0
Volatility
-
Green Energy & Sustainabi...
Gautam Patel
Publish on 13 Apr, 2026
Invests in companies driving renewable energy, EV ecosystem, and sustainable infrastructure growth.
Min. Amount
₹ 6577.86
1D Return
0
Volatility
-
Test
Kandoriya krupal
Publish on 20 Apr, 2026
Just for testing
Min. Amount
₹ 4783.75
1D Return
0
Volatility
-
AngelOne
Ms. Hina Sharma
Publish on 11 May, 2026
AngelOne Stocks
Min. Amount
₹ 106.11
1D Return
0
Volatility
-
Pharma & CDMO Portfolio
DEVARSH JIGISH SHAH
Publish on 20 Apr, 2026
India’s pharmaceutical sector is entering a strong growth phase, driven by global demand and increasing outsourcing opportunities. CDMO (Contract Development and Manufacturing Organization) companies are becoming key partners for global pharma and biotech firms. As companies worldwide look to reduce costs and diversify supply chains beyond China, India is emerging as a preferred destination. India is already one of the largest suppliers of generic medicines and vaccines, with a strong reputation for quality manufacturing and regulatory compliance. The CDMO opportunity is further expanding this advantage into high-value research, development, and manufacturing services. With rising demand for complex drugs, specialty chemicals, and advanced therapies, Indian companies are moving up the value chain and building long-term global relationships. We focus on companies that: Have strong presence in CDMO, APIs, or specialty pharma Benefit from global outsourcing and export growth Show consistent earnings visibility and improving margins Have regulatory approvals and strong client relationships By investing in this portfolio, you get exposure to India’s growing role in the global pharmaceutical supply chain. This portfolio is ideal for long-term investors looking to benefit from a high-growth, export-driven sector with strong global tailwinds.
Min. Amount
₹ 13151.35
1D Return
0
Volatility
-
test
Abhi
Publish on 13 May, 2026
test description
Min. Amount
₹ 174.55
1D Return
0
Volatility
-
Showing 1–12 of 16 results
1
2
